XBiotech Inc.
NASDAQ:XBITBiotechnology
-$0.02 today
- Market cap
- $51.22M
- Beta
- 0.84
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.32
Volume 0.05M
Average 0.03M
Dividends
XBiotech Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
Special
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
1Y Growth
—
3Y CAGR
—
5Y CAGR
—
Dividend Payments, Annual Total (TTM) & Yield
Analysis
The current indicated dividend yield is 0.00%, with TTM dividends of $2.47 per share. The payout ratio is 0.0%, so compare payout growth against earnings coverage. Payments are currently special.
Competitor dividends
How does XBiotech Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Relmada Therapeutics, Inc. NASDAQ:RLMD | $449.08M | 0.00% | $0.00 | 0.00% | 0.00% |
Nutriband Inc. NASDAQ:NTRB | $74.15M | 0.00% | $0.00 | 0.00% | 0.00% |
Adagene Inc. NASDAQ:ADAG | $64.38M | 0.00% | $0.00 | 0.00% | 0.00% |
Fortress Biotech, Inc. NASDAQ:FBIO | $62.70M | 0.00% | $0.00 | 0.39% | 24.48% |
Acrivon Therapeutics, Inc. Common Stock NASDAQ:ACRV | $62.14M | 0.00% | $0.00 | 0.00% | 0.00% |
Gain Therapeutics, Inc. NASDAQ:GANX | $44.36M | 0.00% | $0.00 | 0.00% | 0.00% |
Adicet Bio, Inc. NASDAQ:ACET | $26.03M | 0.00% | $0.00 | 0.00% | 0.00% |
TScan Therapeutics, Inc. NASDAQ:TCRX | $10.20M | 0.00% | $0.00 | 0.00% | 0.38% |
Questions
Dividend questions
Common questions about XBIT's dividend, answered from reported figures.
Does XBIT stock pay dividends?
XBiotech Inc. (XBIT) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is XBIT's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.